In each of these studies, the imaging agents were proteins engineered to have picomolar to single-digit nanomolar dissociation constants for their targets, and the importance of this high affinity for tumor targeting applications is further supported by theoretical modeling [82], motivating additional rounds of mutagenesis and directed evolution for our engineered proteins targeting the novel tumor target MSLN. This evidence concerns the gene MSLN and neoplasm.